|
Ampicillin
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
77.80 |
|
43 |
| Extensive Indoor |
74.80 |
|
41 |
|
|
Ampicillin And Beta-Lactamase Inhibitor
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
43.00 |
|
43 |
| Extensive Indoor |
56.70 |
|
41 |
|
|
Norfloxacin
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
91.30 |
|
43 |
| Extensive Indoor |
74.00 |
|
41 |
|
|
Ofloxacin
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
90.50 |
|
43 |
| Extensive Indoor |
58.30 |
|
41 |
|
|
Nalidixic Acid
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
97.30 |
|
43 |
| Extensive Indoor |
87.70 |
|
41 |
|
|
Erythromycin
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
26.80 |
|
43 |
| Extensive Indoor |
16.20 |
|
41 |
|
|
Ciprofloxacin
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
96.50 |
|
43 |
| Extensive Indoor |
77.40 |
|
41 |
|
|
Tetracycline
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
73.60 |
|
43 |
| Extensive Indoor |
40.80 |
|
41 |
|
|
Sulfamethoxazole And Trimethoprim
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
26.40 |
|
43 |
| Extensive Indoor |
48.00 |
|
41 |
|
|
Chloramphenicol
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
47.00 |
|
43 |
| Extensive Indoor |
7.10 |
|
41 |
|
|
Gentamicin
/
|
Campylobacter spp.
|
| See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
| Organic Production |
13.20 |
|
43 |
| Extensive Indoor |
44.20 |
|
41 |
|